Alison Y Ting1, Brian K Petroff. 1. Breast Cancer Prevention Center, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Abstract
INTRODUCTION: we serendipitously observed a protective effect of tamoxifen against depletion of ovarian follicles by 7,12-dimethylbenzanthracene (DMBA), a chemical carcinogen, during a cancer prevention study. Such ovarian protection is being sought as an alternative approach to fertility preservation in human cancer patients. METHODS: rats received tamoxifen (0, 1 mg or 2.5 mg/kg/d) and DMBA (0, 1, 2 mg/kg/wk) or cyclophosphamide (0, 35, 50 mg/kg/wk). Ovarian follicles were quantified and effects on fertility and litter size were tested. Cultured oocytes were exposed to chemotherapy drug doxorubicin, with or without 4-hydroxytamoxifen (4HT). RESULTS: DMBA and cyclophosphamide decreased the number of primordial and total follicles, and this reduction was prevented by tamoxifen. Cyclophosphamide tended to reduce fertility and lessened neonatal survival. Tamoxifen reversed these defects. Doxorubicin caused oocyte fragmentation which was prevented by 4HT. CONCLUSIONS: tamoxifen decreases follicle loss and improves reproductive function following exposure to ovarian toxicants including chemotherapy drugs in the female rat.
INTRODUCTION: we serendipitously observed a protective effect of tamoxifen against depletion of ovarian follicles by 7,12-dimethylbenzanthracene (DMBA), a chemical carcinogen, during a cancer prevention study. Such ovarian protection is being sought as an alternative approach to fertility preservation in humancancerpatients. METHODS:rats received tamoxifen (0, 1 mg or 2.5 mg/kg/d) and DMBA (0, 1, 2 mg/kg/wk) or cyclophosphamide (0, 35, 50 mg/kg/wk). Ovarian follicles were quantified and effects on fertility and litter size were tested. Cultured oocytes were exposed to chemotherapy drug doxorubicin, with or without 4-hydroxytamoxifen (4HT). RESULTS:DMBA and cyclophosphamide decreased the number of primordial and total follicles, and this reduction was prevented by tamoxifen. Cyclophosphamide tended to reduce fertility and lessened neonatal survival. Tamoxifen reversed these defects. Doxorubicin caused oocyte fragmentation which was prevented by 4HT. CONCLUSIONS:tamoxifen decreases follicle loss and improves reproductive function following exposure to ovarian toxicants including chemotherapy drugs in the female rat.
Authors: A A Ezzat; E M Ibrahim; R K Stuart; D Ajarim; S Bazarbashi; M O El-Foudeh; M Rahal; A Al-Sayed; J Berry Journal: Med Oncol Date: 2000-02 Impact factor: 3.064
Authors: Joanna Piasecka-Srader; Fernando F Blanco; Devora H Delman; Dan A Dixon; James L Geiser; Renata E Ciereszko; Brian K Petroff Journal: Biol Reprod Date: 2015-04-01 Impact factor: 4.285
Authors: Sana M Salih; Ashley K Ringelstetter; Mazin Z Elsarrag; David H Abbott; Elon C Roti Roti Journal: Biol Reprod Date: 2015-01-21 Impact factor: 4.285
Authors: Loro L Kujjo; Eun A Chang; Ricardo J G Pereira; Shilpa Dhar; Brenda Marrero-Rosado; Satyaki Sengupta; Hongbing Wang; Jose B Cibelli; Gloria I Perez Journal: PLoS One Date: 2011-03-17 Impact factor: 3.240
Authors: Jenna Kropp; Elon C Roti Roti; Ashley Ringelstetter; Hasan Khatib; David H Abbott; Sana M Salih Journal: PLoS One Date: 2015-11-06 Impact factor: 3.240